Mode
Text Size
Log in / Sign up
N/A N=147 Randomized Double-blind Treatment

Comparing KIM to TVT Exact Sling

Stress Urinary Incontinence

Enrolled (actual)
147
Serious AEs
0.0%
Results posted
Aug 2023
Primary outcome: Primary: Number of Participants With Treatment Success at 6 Weeks After Surgery — 61; 51 Participants — p=0.04

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Gynecare TVT Exact Continence System (Device); Neomedic KIM (Knotless Incontinence Mesh) (Device)
Age
Adult, Older Adult · 21+ yrs
Sex
Female
Sponsor
University of North Carolina, Chapel Hill
Primary completion
May 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants With Treatment Success at 6 Weeks After Surgery
61; 51 0.04 sig
SECONDARY
Number of Participants With Treatment Success at 1 Year After Surgery
55; 53 0.29
SECONDARY
Number of Participants Requiring Reoperation for Mesh Complications or Urinary Retention Thru 1 Year After Surgery
0; 0
SECONDARY
Number of Participants With Mesh Exposure Thru 1 Year After Surgery
6; 1 0.11

Summary

To assess to the non-inferiority of the retropubic Neomedic Knotless Incontinence Mesh (KIM) sling compared to the Gynecare Tension-free Vaginal Tape (TVT) Exact sling. Participants: Women 21 years or older with a diagnosis of stress urinary incontinence (SUI) or mixed urinary incontinence (MUI) with objective evidence of SUI planning surgery for stress urinary incontinence. Procedures (methods): Patients will be randomized to receive either the Gynecare TVT Exact sling or the retropubic Neomedic KIM sling. Patients will be followed for 1 year postoperatively.

Eligibility Criteria

Inclusion Criteria

  • Women greater than or equal to 21 years based on medical chart review
  • Diagnosis of SUI or mixed urinary incontinence based on medical chart review
  • Objective evidence of SUI as indicated by positive cough stress test or urodynamic stress incontinence during urodynamic testing within the last year prior to enrollment. Medical chart will be reviewed.
  • Planning surgery for SUI with/without pelvic organ prolapse (POP) surgery

Exclusion Criteria

  • Current pregnancy, desire for future childbearing, less than or equal to 12 months postpartum at the time of enrollment
  • Prior history of surgery for SUI based on medical chart review
  • Bladder capacity 150 mL on urodynamic testing or bladder scan.
  • Non-ambulatory
  • Current genitourinary fistula or urethral diverticulum based on pre-operative exam in the medical chart.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04985799). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search